Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biolase Inc (BIOL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7489
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diode systems. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance service. The company distributes its products through direct sales force, agents and distributors. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.

Biolase Inc (BIOL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biolase Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Partnerships 13
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Equity Offering 21
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For US$5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To US$12.5 Million 31
Biolase Completes Private Placement Of Shares For US$5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For US$5 Million 33
Asset Transactions 34
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc – Key Competitors 35
Biolase Inc – Key Employees 36
Biolase Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
May 02, 2018: BIOLASE Announces 2018 First Quarter Results 38
Nov 01, 2017: BIOLASE Reports 2017 Third Quarter and Nine-Month Results 40
Aug 07, 2017: BIOLASE Reports 2017 Second Quarter and Six-Month Results 42
May 03, 2017: BIOLASE Reports 2017 First Quarter Results 44
Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results 46
Corporate Communications 48
Aug 08, 2018: BIOLASE names Todd A. Norbe President, Chief Executive Officer 48
Jun 19, 2018: BIOLASE Names Todd A. Norbe And Jess Roper As Board Directors 49
Apr 11, 2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options 50
Apr 04, 2018: BIOLASE Names Garrett Sato To Board Of Directors 51
Mar 07, 2018: BIOLASE Secures $6 Million Revolving Line Of Credit 52
Oct 31, 2017: BIOLASE Appoints Richard B. Lanman to Board of Directors 53
Oct 02, 2017: BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer 54
Sep 05, 2017: BIOLASE Names Jonathan T. Lord Chairman of the Board 55
May 05, 2017: BIOLASE Announces Management Change 56
Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas 57
Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer 58
Jan 09, 2017: BIOLASE Announces Management Change 59
Legal and Regulatory 60
Jan 25, 2018: BIOLASE Rejects Frivolous, Abusive Patent Litigation 60
Jan 24, 2018: CAO Group Protects Its Diode Laser Patent Rights From Infringement By Biolase 61
Government and Public Interest 62
Mar 28, 2018: BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry 62
Other Significant Developments 63
Sep 12, 2018: BIOLASE Expands Its Initiative to Increase Dental Laser Awareness to Dallas-Fort Worth Area 63
May 09, 2018: BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California 64
Feb 15, 2018: BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
Biolase Inc, Medical Equipment, Key Facts, 2017 2
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For US$5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To US$12.5 Million 31
Biolase Completes Private Placement Of Shares For US$5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For US$5 Million 33
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc, Key Competitors 35
Biolase Inc, Key Employees 36
Biolase Inc, Subsidiaries 37

List of Figures
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sierra Nevada Corporation:企業の戦略・SWOT・財務情報
    Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report Summary Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Reinhart FoodService L.L.C.:企業の戦略・SWOT・財務分析
    Reinhart FoodService L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Reinhart FoodService L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • Leclanche SA (LECN):電力:M&Aディール及び事業提携情報
    Summary Leclanche SA (Leclanche) is a custom battery storage solutions provider. The company develops and manufactures energy storage systems with large format lithium-ion cells. It also offers batteries and storage systems including portable energy systems, accumulators, torches and chargers. The c …
  • Teva Pharmaceutical Industries Ltd (TEVA)-医療機器分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Taiyo Nippon Sanso Corp (4091):企業の財務・戦略的SWOT分析
    Taiyo Nippon Sanso Corp (4091) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Narodowy Bank Polski:企業の戦略的SWOT分析
    Narodowy Bank Polski - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that offers prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, horm …
  • TD Ameritrade Holding Corporation:企業の戦略・SWOT・財務情報
    TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Office Depot, Inc.:企業のM&A・事業提携・投資動向
    Office Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Office Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Reynolds American Inc.:企業の戦略的SWOT分析
    Reynolds American Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務分析
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Electrovaya Inc (EFL):企業の財務・戦略的SWOT分析
    Electrovaya Inc (EFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆